Immunogenicity in humans of an edible vaccine for hepatitis B. - Wikidata - awgldk - TriplyDB

Immunogenicity in humans of an edible vaccine for hepatitis B.

Immunogenicity in humans of an edible vaccine for hepatitis B.

http://www.wikidata.org/entity/Q33858661

about

Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status Virus-like particles production in green plants The Potential for Microalgae as Bioreactors to Produce Pharmaceuticals Plants as Factories for Human Pharmaceuticals: Applications and Challenges Plant-based vaccines for animals and humans: recent advances in technology and clinical trials Farming of Plant-Based Veterinary Vaccines and Their Applications for Disease Prevention in Animals Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants Commercial-scale biotherapeutics manufacturing facility for plant-made pharmaceuticals Plant-made oral vaccines against human infectious diseases-Are we there yet?The mucosal immune system: From dentistry to vaccine development The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B Is there a role for plant-made vaccines in the prevention of HIV/AIDS?Next biotech plants: new traits, crops, developers and technologies for addressing global challenges.Expression of HIV-1 antigens in plants as potential subunit vaccines Vaccination via Chloroplast Genetics: Affordable Protein Drugs for the Prevention and Treatment of Inherited or Infectious Human Diseases Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system.Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.Plant-based vaccines against viruses.Hepatocytes traffic and export hepatitis B virus basolaterally by polarity-dependent mechanisms Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses.Oral vaccines: A spoonful of antigen.Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles.Oral hepatitis B vaccine candidates produced and delivered in plant material.Regulatory issues for plant-made pharmaceuticals and vaccines.A launch vector for the production of vaccine antigens in plants.Assessing commercial feasibility: a practical and ethical prerequisite for human clinical testing.Plant-made vaccines: biotechnology and immunology in animal health.Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead.Protein glycosylation in diverse cell systems: implications for modification and analysis of recombinant proteins.The twenty-year story of a plant-based vaccine against hepatitis B: stagnation or promising prospects?Delivery systems and adjuvants for oral vaccines.Production of pharmaceutical proteins in solanaceae food crops.Implication of nanoparticles/microparticles in mucosal vaccine delivery.Plant-derived virus-like particles as vaccines Needle-free vaccine delivery.Oral vaccine delivery: can it protect against non-mucosal pathogens?Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes.Plant-made vaccine antigens and biopharmaceuticals.Transgenic plant-based oral vaccines.

P2860

Q24241852-F42D3950-3FF7-47AC-88FD-058510CD99C9 Q24650772-1680CC56-9F04-4A29-A63B-7882D2DD10E1 Q26744351-D91577AA-8B15-4EFE-98E3-242EFBEFE121 Q26775069-5D21D725-80C6-4B8C-9DF8-D46B2DCC800C Q26775788-8B0B6CEC-96B8-4666-89F2-628DB722C655 Q26782486-01EF839D-D8ED-4852-8FC1-D57CE3A3A730 Q26782569-8A813EB3-E36F-4DCD-975A-876166837864 Q26783099-3162BAA6-3E59-4721-BCCF-36764C10BF4F Q26783111-4B6FB3B9-E041-45E6-B9F1-7EA4DFC3F125 Q26783887-FFEA5BFF-2448-48BA-94A3-923276F5D8D9 Q28073401-2181483D-BFA5-4CF9-BF46-31898A75EE44 Q30350670-AD05CA89-20E4-4360-BCA8-326F2DCE3778 Q30886978-243B9DF8-9F49-4C1B-8A55-5C147063198B Q33345905-2A51BCF3-8C30-4F77-B8EE-792B64074302 Q33870122-87FE3DBB-766B-423C-8563-BD0AD6219BA8 Q34250117-8F22EAA8-2341-4514-811E-D931B9AA9DAE Q34617331-1A2EE0F4-ABAF-49AE-BA10-E06344B93E8D Q34687464-A56846E1-3BE4-4273-89B3-076F41BEA9AA Q35531633-068C9D88-70D5-44BD-8E42-F1D701734073 Q35598223-C085C8C0-80FA-4886-84DC-9218B95DDB12 Q35653717-D7E0FBF9-AA91-4516-A5D4-05165734B52A Q35915872-FCF3D6C4-69E7-4B4F-A215-F09AFF0B1501 Q35960908-7A6D094D-7929-4F1E-9105-FB21F4467749 Q36118497-90ABF043-BE3C-43E1-B9C8-4BF38E660388 Q36238737-5AF72FDD-A2F2-459F-B3D4-F076FB850439 Q36252789-841977FA-C691-42BF-91D5-8AC54385D341 Q36436921-3730CAD4-94D5-40F7-90CF-F78719FA97D2 Q36439033-BDBEC127-4478-46AE-8CFB-083B250A1EC4 Q36445550-316F8575-CDAE-4B93-A129-11862E0320B0 Q36505675-FFF0E9DF-3C28-4464-A1CB-976A36BE1EC7 Q36590168-B781AC8E-87E8-499A-A4B0-3090F31E9D41 Q36640326-722654FC-6A2B-4690-8630-3CD6149D01E2 Q36655994-D8BD9866-AF87-4A93-AA91-9F6436E5702E Q36837152-B0886AC5-20E6-4928-920C-AE1895A83720 Q36888029-E770582A-1D91-4B01-8AFE-77C1FD9E4807 Q36945838-B5070C6E-EBD1-4BD6-9FDC-53EFA014F36A Q37229915-DAEFE839-C9DC-4C9C-8C2F-980A111FE2A9 Q37324787-2CEE0F52-EC18-4B5E-8052-0AAA9B865283 Q37616370-A853804D-0DF6-414B-9650-1CB8F27FB5D0 Q37744913-09898525-BF19-4B7A-8392-84A3198A303E

P2860

Immunogenicity in humans of an edible vaccine for hepatitis B.

http://www.wikidata.org/entity/Q33858661

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Immunogenicity in humans of an edible vaccine for hepatitis B.

@ast

Immunogenicity in humans of an edible vaccine for hepatitis B.

@en

type

label

Immunogenicity in humans of an edible vaccine for hepatitis B.

@ast

Immunogenicity in humans of an edible vaccine for hepatitis B.

@en

prefLabel

Immunogenicity in humans of an edible vaccine for hepatitis B.

@ast

Immunogenicity in humans of an edible vaccine for hepatitis B.

@en

P1433

Q33858661-33BF1DCA-4E44-4649-A072-DF38D3E0EB4C

P1476

Q33858661-D38ABAE5-B9CA-4509-AA92-BB6D5E7E481D

P2093

Q33858661-0C9A2550-29EF-46B5-A1A1-8D33047E6F51

Q33858661-4EEFE0A6-51BC-47C7-87CA-694D589FF95B

Q33858661-6323EB91-E11C-4EE6-8810-50FFC9C856C9

Q33858661-8370AEE5-0622-45A8-A5D7-69B77A2A6E39

Q33858661-83BB2E26-E43F-4476-AD96-D1623504CF21

Q33858661-8CDAD2E7-FC42-4FCE-B1F2-8F7AF3382802

Q33858661-91C2656E-56EF-44EC-B6F4-0C6D0D2C8DA2

Q33858661-CD934EDF-7781-494E-96C1-4FA275C96C2F

Q33858661-F073FC6D-9BB8-4DB4-A70D-ACC23570B2FE

P2860

Q33858661-20BBC6B3-A399-435C-BFF5-0F175E4E5D43

Q33858661-24B3B176-8D8B-4A24-9040-43F6ACA3F335

Q33858661-3672472C-8513-4083-AA37-9754615CDB25

Q33858661-3D24132A-53B8-4582-9E68-E01655D4C85F

Q33858661-404544F7-72F8-40C1-9692-981710C7FFC3

Q33858661-47C064A8-2DA6-4F79-8659-B9B9A823DC48

Q33858661-493B302E-B118-4FF2-A301-AD13C491E662

Q33858661-885BEA3E-13BA-49E5-B10F-BBD7E653A726

Q33858661-89309882-3BFB-4913-8653-A9A03A54CD11

Q33858661-A461CB27-BBC2-4D61-B936-A983B139B1C5

P304

Q33858661-1750C108-5CAD-4855-B314-F564036EBA7B

P31

Q33858661-8D5F8EEB-A723-4BAA-8D23-B5CEC1B6FF21

P356

Q33858661-66B62CE6-5FF5-4C27-A1FC-5EB5EDDDB261

P407

Q33858661-B2E9A596-D014-4BEC-B76B-2D2F0E980ACC

P433

Q33858661-91F8D3E3-2D88-4708-B0E1-A170444FDFC3

P478

Q33858661-5741CAC2-FEAC-4F68-AB11-D718120A6D92

P577

Q33858661-1BDDB8A4-E38D-428C-A6C4-A872D279B959

P5875

Q33858661-0530CC5E-9B6A-4AED-9454-EE265D491582

P698

Q33858661-24EA0C8F-D546-4475-A90E-14D41FFA1196

P932

Q33858661-06926312-0A01-41CE-87B8-BBFDF816D024

P356

PNAS.0409899102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Immunogenicity in humans of an edible vaccine for hepatitis B.

@en

P2093

Adrienne Scott

http://www.w3.org/2001/XMLSchema#string

Charles J Arntzen

http://www.w3.org/2001/XMLSchema#string

Hugh S Mason

http://www.w3.org/2001/XMLSchema#string

Liz Richter

http://www.w3.org/2001/XMLSchema#string

Martin Mahoney

http://www.w3.org/2001/XMLSchema#string

Nachimuthu Natarajan

http://www.w3.org/2001/XMLSchema#string

Patti Goodwin

http://www.w3.org/2001/XMLSchema#string

Sribani Pal

http://www.w3.org/2001/XMLSchema#string

Yasmin Thanavala

http://www.w3.org/2001/XMLSchema#string

P2860

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

Oral immunization with hepatitis B surface antigen expressed in transgenic plants.

Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene.

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

Expression of hepatitis B surface antigen in transgenic plants

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

Serologic hepatitis B immunity in vaccinated health care workers.

Novel hepatitis B vaccines.

Vaccine visions and their global impact.

Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies.

P304

3378-3382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0409899102

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8006029

http://www.w3.org/2001/XMLSchema#string

P698

15728371

http://www.w3.org/2001/XMLSchema#string

P932

549291

http://www.w3.org/2001/XMLSchema#string